With preparations underway for a possible launch of the vaccine in January, India’s drug regulator is looking to the UK, which sources say may give Oxford its go-ahead. COVID-19 vaccine next week, before deciding to give emergency use authorization to the Serum Institute that makes the injections here. Once the …
Read More »
Coronavirus News LIVE Updates: The South African variant of Covid-19, two cases of which have now been detected in the UK, is likely to be more transmissible, may affect young people more, and may be slightly more resistant to vaccines, scientists in South Africa believe. However, research is still continuing …
Read More »
NEW DELHI: India is likely to approve the Oxford / AstraZeneca coronavirus vaccine for emergency use next week after its local manufacturer submitted additional data requested by authorities, two sources with knowledge of the matter told Reuters on Tuesday. This could be the first country to give a regulatory green …
Read More »
LONDON: The University of Oxford vaccine against Covid-19 produced by AstraZeneca It is likely to get regulatory approval from the UK’s independent regulator later this year to begin rollout in early 2021, according to a UK media report. The Medicines and Health Regulatory Agency (MHRA), formally tasked by the UK …
Read More »
LONDON: Oxford’s Covid-19 vaccine candidate has a better immune response when using a two full dose regimen rather than a full dose followed by a half-dose booster dose, the university said Thursday. The candidate vaccine, which has been licensed to AstraZeneca, has published the results of an interim late-stage trial …
Read More »
LONDON: Oxford University’s Covid-19 candidate vaccine has a better immune response when using a two-full-dose regimen rather than a full dose followed by a half-dose booster, the university said Thursday, citing data from the first trials. The developers of the candidate vaccine, which has been licensed to the pharmaceutical company …
Read More »
LONDON: Oxford’s Covid-19 vaccine candidate has a better immune response when using a two full dose regimen rather than a full dose followed by a half-dose booster dose, the university said Thursday. The candidate vaccine, which has been licensed to AstraZeneca, has published the results of an interim late-stage trial …
Read More »
NEW DELHI: India will have to spend between $ 1.4 billion and $ 1.8 billion on the first phase of a coronavirus vaccination program, even after receiving support under the global Covax vaccine exchange scheme, according to estimates by the GAVI vaccine alliance. India, which has the world’s second-highest number …
Read More »
NEW DELHI: With Americans, British and Canadians rolling up their sleeves for coronavirus vaccines, the route out of the pandemic now seems clear to many in the West, even if implementation will take many months. But for the poorest countries, the road will be much longer and bumpier. The ambitious …
Read More »
NEW DELHI: Trade and investment with UK Pushing India for a free trade agreement, alongside Indo-Pacific, defense and security and early recovery cooperation from Covid-19, dominated the agenda of Tuesday’s meeting between the UK’s secretary of state for foreign affairs, Dominic Raab, and his counterpart S Jaishankar. Raab, the second …
Read More »